Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
Molecular Models
Conserved Binding Sites
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 28, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Corentin Bedart1, Conrad Veranso Simoben2, Matthieu Schapira3
1Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000, Lille, France.
Structure-based virtual screening identifies drug candidates by predicting protein interactions. New machine learning and synthon-based methods accelerate screening of vast chemical libraries, overcoming computational limitations for drug discovery.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: